If You’re Allergic to Wasps, Are You Allergic to Bees?

Bees and wasps belong to the order Hymenoptera, which also includes ants. An allergic reaction is a serious immune response where the body mistakenly identifies specific proteins in the insect’s venom as a threat, producing immunoglobulin E (IgE) antibodies. Since the venom composition differs significantly between insect types, the simple answer is complicated and depends entirely on the specific proteins your immune system reacts to.

Differences in Stinging Insect Families

Bees and wasps belong to separate families within the Hymenoptera order, which dictates their physical traits and venom makeup. Bees, such as the honey bee (Apis) and bumblebee (Bombus), are classified in the family Apidae. Their bodies are robust and covered in dense, fuzzy hairs, aiding their primary role as pollinators. Honey bees leave their barbed stinger and venom sac behind after a single sting, resulting in the insect’s death, while bumblebees can sting multiple times.

Wasps, including yellow jackets (Vespula), hornets (Vespa), and paper wasps (Polistes), are part of the family Vespidae. These insects have sleek, less hairy bodies with a distinct, narrow waist, making them efficient predators and scavengers. Unlike honey bees, vespids possess a smooth stinger, allowing them to sting repeatedly.

Distinct Components of Bee and Wasp Venoms

The severity of an allergic reaction hinges on the unique proteins in the venom that trigger the immune response. Bee venom, primarily from the honey bee, contains major allergens such as phospholipase A2 (Api m 1) and melittin. These enzymes and peptides are highly immunogenic and account for the majority of severe allergic reactions to bee stings.

Wasp venom, particularly from yellow jackets, contains a different set of primary allergens, most significantly Antigen 5 (Ves v 5) and hyaluronidase (Ves v 1). Because these dominant proteins are chemically distinct, an individual sensitized to the major bee protein (Api m 1) is not automatically allergic to the major wasp protein (Ves v 5).

Understanding Cross-Reactivity

Despite the differences in primary allergens, many patients who react to one venom also show a positive result when tested for the other, a phenomenon known as cross-reactivity or double sensitization. Studies show that between 30% and 59% of patients with Hymenoptera venom allergy may test positive for both bee and wasp venoms. This dual reactivity is often caused by minor shared components, rather than a true separate allergy to both insects.

The most common cause of non-specific dual reactivity is the presence of IgE antibodies directed against Cross-Reactive Carbohydrate Determinants (CCDs). CCDs are sugar molecules attached to venom proteins that are structurally similar across different insect species. While IgE antibodies to CCDs are detectable in a blood test, they are generally considered to have low clinical relevance and do not usually cause a true systemic allergic reaction. A true double sensitization, where an individual has IgE antibodies to the major, species-specific allergens of both a bee (Api m 1) and a wasp (Ves v 5), is less common than sensitization driven by CCDs.

Medical Testing and Action Steps

For anyone who has experienced a severe reaction to a sting, consulting an allergist is the appropriate first step. The allergist will use diagnostic tools to determine the specific insect responsible for the allergic reaction. Testing typically includes a skin prick test and an intradermal skin test, where small amounts of purified venoms from honey bees, yellow jackets, hornets, and wasps are introduced to the skin.

Diagnostic Testing

These tests are often supplemented by specific IgE blood tests, which measure the amount of venom-specific IgE antibodies in the blood. Molecular component testing looks for IgE to the specific major allergens like Api m 1 and Ves v 5. This helps distinguish between a true double allergy and clinically irrelevant cross-reactivity caused by CCDs.

Treatment and Management

If an allergy is confirmed, the primary management strategy involves carrying an epinephrine auto-injector for emergency use. Long-term treatment often includes venom immunotherapy (allergy shots). This involves injecting gradually increasing doses of the specific venom extract to desensitize the immune system, reducing the risk of a severe systemic reaction to future stings.